AbbVie Chief Commercial Officer Jeffrey Stewart Sells $11.93 Million of Stock After Option Exercise
AbbVie Chief Commercial Officer Jeffrey Stewart sold $11.93 million of the drugmaker's stock this week after exercising stock options, according to a Form 4 filed Thursday.
Stewart, an executive vice president, exercised two option awards on Nov. 9: 16,070 shares at an exercise price of $114.36 and 24,549 shares at $93.50, the filing shows. He sold 40,619 shares the same day at a weighted average price of $293.60, for $11,925,738.
A footnote says the shares were sold in multiple transactions at prices ranging from $293.54 to $293.82.
Holdings after the trades
Stewart directly held 83,171 shares after the sale. On Nov. 12 he reported a gift of 3,450 shares, leaving 79,721 shares held directly, according to the Form 4. The filing also lists 1,338 shares held by his spouse in trust, for which he disclaims beneficial ownership.
The exercise used up the first award, granted under AbbVie's Amended and Restated 2013 Incentive Stock Program. He still held 24,550 options from the second award afterward.
No trading plan noted
The Form 4 does not indicate that the sale was made under a Rule 10b5-1 trading plan.
By the numbers
- Options exercised: 40,619 shares across two awards
- Shares sold: 40,619 at a weighted average of $293.60
- Sale value: $11,925,738
- Gift on Nov. 12: 3,450 shares
- Direct holdings afterward: 79,721 shares
Sources
- Form 4, Jeffrey Ryan Stewart, AbbVie Inc., filed Nov. 12, 2026, accession 0001761675-26-000007
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence. SI may make mistakes.